PubMed Health⌕ Search

Biomedical subjects

B Meiklejohn

Publications and source records attributed to B Meiklejohn.

7 recordsLinked to original sources
PubMed1997

Healthy aboriginal communities.

Improving the health of Aboriginal and Torres Strait Islander populations is the greatest challenge facing public health in Australia today. The gains in the health of the population overall have not been matched by gains among these communities. Much of the information about the health of Aboriginal and Torres Strait Islander communities and people is negative, and little information is available about what Aboriginal and Torres Strait Islander people themselves consider to be indicators of healthy people and healthy communities. This paper identifies some successful programs and highlights the need for community ownership of decisions about goals, services and programs. By looking to ways that Aboriginal people view their health (and its determinants), and to the examples of successful action to date, it is possible to begin to develop a vision of healthy Aboriginal communities in which the relationship between body, land and spirit has been restored. The need, now, is to build the partnerships that will be necessary to turn the vision into reality.

Attitude to Health↗
PubMed1997

Fluorescent dye assay for detection of DNA in recombinant protein products.

A homogeneous fluorescence-based DNA detection system has been developed to measure DNA in protein solutions. The technique relies on the increase in fluorescence of a dye molecule when it intercalates into double-stranded (ds) DNA. The increased fluorescence is a direct measurement of the amount of DNA in the sample. The analysis time required per sample is less than 5 min. The dye has absorbance and emission maxima at 485 and 530 nm, respectively. The assay is linear from 98 pg/mL to 200 ng/mL of DNA in buffers containing no proteins with typical relative standard deviation values of less than 2.4%. The assay performance was evaluated under various matrix conditions, including buffers, pH, ionic salts, detergents, denaturants and organic solvents. Each reagent was tested at several concentrations to determine how the slope and linearity (r value) of the standard curve were affected. Even in the presence of matrix components and protein, the assay was able to quantitatively detect picogram to nanogram levels of DNA. The fluorescence can be removed by DNase treatment. This method is specific for dsDNA with RNA emitting less than 2% intensity of an equivalent mass of DNA.

Buffers↗
PubMed1990

Improved methods for separation of human cytokeratins.

The cytokeratins from human bladder and esophageal epithelia were separated using chromatographic techniques. The cytokeratins were first extracted from fresh autopsy tissue using high and low salt buffers. Urea, 8.0-9.5 M, was used to solubilize the resulting cytokeratin pellet. Imidazole was found to increase the solubility of the pellet but reducing agents such as 2-mercaptoethanol were not beneficial. DEAE ion exchange chromatography produced three fractions which were analyzed by using one and two-dimensional electrophoresis. The third fraction was shown to contain the acidic cytokeratins and was further fractionated on a moderately polar reverse phase HPLC column using an acetonitrile elution gradient. Tetramethylammonium tetrafluoroborate was added to the mobile phase to react with any unreacted silanol groups on the stationary phase, and trifluoroacetic acid was added to ion pair with the protein. HPLC fractions of the acidic proteins from human esophagus revealed seven reproducible peaks. All seven peaks were shown by Western blotting to contain an epitope found on cytokeratin 13. The results suggest that the isolation and separation procedures have produced a series of peptide products which all retain a similar epitope but which vary significantly in their hydrophobic characteristics.

Chromatography, High Pressure Liquid↗
PubMed1990

Precision and accuracy of a portable blood analyzer system during cholesterol screening.

The precision and accuracy of two Kodak Ektachem DT-60 portable blood analyzers were assessed in a model (research) cholesterol screening program in Rochester, New York. Between June and October 1987, a total of 8,573 people underwent a cholesterol screening held in a movable trailer. A wide variety of temperature, humidity, and other potentially adverse conditions were encountered during the screening period. Between-run coefficients of variation ranged from 1.9 percent to 4.8 percent per month; average bias compared to a Reference Laboratory method ranged between +0.2 percent and +2.0 percent. Both precision and accuracy met currently recommended standards for cholesterol testing in the United States.

Allied Health Personnel↗
PubMed1990

Blood cholesterol concentration: fingerstick plasma vs venous serum sampling.

To assess whether venous and fingerstick blood samples yield similar cholesterol concentrations, we obtained both types of samples simultaneously in 108 volunteers participating in a cholesterol screening program. All samples were analyzed by the same enzymatic method in a standardized laboratory, and pairs of simultaneous samples were measured in the same laboratory run. Cholesterol concentrations in fingerstick-derived plasma were consistently higher than in the venous serum (P less than 0.0001), by a positive bias averaging 3.6%. Cholesterol values in fingerstick plasma also were higher than cholesterol results for venous serum placed in a capillary collection tube (average bias +2.4%). The positive bias of fingerstick plasma vs venous serum results appears to be at least partly due to specimen handling, although a true physiological difference between venous and fingerstick cholesterol concentrations is probably also involved. If a positive bias of this magnitude from fingerstick blood sampling is left unadjusted, substantial numbers of people will be labeled "at risk" and referred to physicians when their true values were actually within the acceptable range.

Blood Specimen Collection↗
PubMed1984

Bupivacaine and prilocaine in intravenous regional anaesthesia.

Six volunteers underwent intravenous regional anaesthesia of the non-dominant arm on four occasions using two equipotent doses of bupivacaine and prilocaine, administered in a randomised double-blind sequence. Equipotent doses produced similar degrees of motor and sensory blockade. Bupivacaine produced more rapid motor power loss and delayed motor recovery (p less than 0.01). Prilocaine produced more prolonged objective blockade following tourniquet release (p less than 0.01), although this was not clinically useful, and bupivacaine led to a marked prolongation of subjective blockade (p less than 0.01). Increase of dose with both drugs gave more rapid and complete sensory and motor blockade and delayed recovery (p less than 0.05). This was, however, associated with more marked toxicity. It is suggested that in intravenous regional anaesthesia there are no clinical differences between the drugs in equipotent solutions, and that the lower concentrations are the appropriate ones for standard use.

Adult↗